In a small clinical study of 30 patients with stable COPD treatment with low-dose slow-release theophylline plus low-dose inhaled fluticasone significantly reduced sputum neutrophils and improved lung function, and this was associated with an increase in HDAC2 activity in circulating peripheral blood monocytes.83 This evidence concerns the gene HDAC2 and chronic obstructive pulmonary disease.